Heart rate, body temperature and physical activity are variously affected during insulin treatment in alloxan-induced type 1 diabetic rat

Physiological Research

Volumn 60, Issue 1, 2011, Pages 65-73

  Howarth, F C ^a   Jacobson, M ^b   Shafiullah, M ^a   Ljubisavljevic, M ^a   Adeghate, E ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b HIGHER COLLEGES OF TECHNOLOGY   (United Arab Emirates)

Author keywords

Alloxan; Body temperature; Diabetes mellitus; Heart rate; Insulin; Physical activity

Indexed keywords

EID: 79955864002     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: 10.33549/physiolres.931984     Document Type: Article

References (40)

1. Altura BM, Lum G, Turlapaty PD, Altura BT. Sequential changes in serum glucose, triglycerides and cholesterol in aging of normal and alloxan-diabetic rats. Experientia 37: 224-226, 1981.
2. Balkman C, Ojamaa K, Klein I. Time course of the in vivo effects of thyroid hormone on cardiac gene expression. Endocrinology 130: 2001-2006, 1992.
3. Bootsma M, Swenne CA, Van Bolhuis HH, Chang PC, Cats VM, Bruschke AV. Heart rate and heart rate variability as indexes of sympathovagal balance. Am J Physiol 266: H1565-H1571, 1994.
4. Casis O, Echevarria E. Diabetic cardiomyopathy: electromechanical cellular alterations. Curr Vasc Pharmacol 2: 237-248, 2004.
5. Chen ZQ, Hu S J, Xia Q, Shen YL. [Effect of adenosine on electrophysiological changes of ventricular myocardium in rats with experimental diabetes]. (in Chinese) Zhejiang Da Xue Xue Bao Yi Xue Ban 33: 437-442, 2004.
6. Dhalla NS, Pierce GN, Innes IR, Beamish RE. Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol 1: 263-281, 1985.
7. Di Meo S, De Martino RP, De Leo T. Thyroid state and electrical properties of rat papillary muscle fibres. Arch Int Physiol Biochim Biophys 99: 377-383, 1991.
8. Fazan R Jr, Dias Dsv, Ballejo G, Salgado HC. Power spectra of arterial pressure and heart rate in streptozotocin-induced diabetes in rats. J Hypertens 17: 489-495, 1999.
9. Ferrari AU, Daffonchio A, Albergati F, Mancia G. Inverse relationship between heart rate and blood pressure variabilities in rats. Hypertension 10: 533-537, 1987.
10. Galinanes M, Smolenski RT, Haddock Ps, Hearse DJ. Early effects of hypothyroidism on the contractile function of the rat heart and its tolerance to hypothermic ischemia. J Thorac Cardiovasc Surg 107: 829-837, 1994.
11. Garber DW, Everett AW, Neely JR. Cardiac function and myosin ATPase in diabetic rats treated with insulin, T3, and T4. Am J Physiol 244: H592-H598, 1983.
12. Garber DW, Neely JR. Decreased myocardial function and myosin ATPase in hearts from diabetic rats. Am J Physiol 244: H586-H591, 1983.
13. Howarth FC, Jacobson M, Naseer O, Adeghate E. Short-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats. Exp Physiol 90: 237-245, 2005a.
14. Howarth FC, Jacobson M, Shafiullah M, Adeghate E. Long-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats. Exp Physiol 90: 827-835, 2005b.
15. Howarth FC, Jacobson M, Shafiullah M, Adeghate E. Effects of insulin treatment on heart rhythm, body temperature and physical activity in streptozotocin-induced diabetic rat. Clin Exp Pharmacol Physiol 33: 327-331, 2006.
16. Julien J. Cardiac complications in non-insulin-dependent diabetes mellitus. J Diabetes Complications 11: 123-130, 1997.
17. Karasu C, Ozturk Y, Altan N, Yildizoglu-Ari N, Ikizler C, Altan Vm. Thyroid hormones mediated effect of insulin on alloxan diabetic rat atria. Gen Pharmacol 21: 735-740, 1990.
18. Krahulec B, Mikes Z, Balazovjech I. The effect of cardiovascular autonomic neuropathy on resting ECG in type 1 diabetic patients. Bratisl Lek Listy 103: 54-58, 2002.
19. Kulkarni JS, Metha AA, Santani DD, Goyal RK. Effects of chronic treatment with cromakalim and glibenclamide in alloxan-induced diabetic rats. Pharmacol Res 46: 101-105, 2002.
20. Lee JH, Konarska M, Mccarty R. Physiological responses to acute stress in alloxan and streptozotocin diabetic rats. Physiol Behav 45: 483-489, 1989.
21. +-current in QT prolongation in the alloxan-induced diabetic rabbit heart. Acta Physiol (Oxf) 192: 359-368, 2008.
22. Lengyel C, Virág L, Bíró T, Jost N, Magyar J, Biliczki P, Kocsis E, Skoumal R, Nánási Pp, Tóth M, Kecskemèti V, Papp Jg, Varró A. Diabetes mellitus attenuates the repolarization reserve in mammalian heart. Cardiovasc Res 73: 512-520, 2007.
23. Lo GP, Careddu A, Magni G, Quagliata T, Pacifici L, Carminati P. Autonomic neuropathy in streptozotocin diabetic rats: effect of acetyl-L-carnitine. Diabetes Res Clin Pract 56: 173-180, 2002.
24. Lortet S, Zimmer HG, Rossi A. Inotropic response of the rat heart during development and regression of triiodothyronine-induced hypertrophy. J Cardiovasc Pharmacol 14: 707-712, 1989.
25. Mcdonough KH, Chen V, Spitzer JJ. Effect of altered thyroid status on in vitro cardiac performance in rats. Am J Physiol 252: H788-H795, 1987.
26. Ozcelikay AT, Yidizoglu-Ari N, Ozuari A, Ozturk Y, Altan VM. The effect of vanadate on alloxandiabetic rat atria. Diabetes Res Clin Pract 19: 189-194, 1993.
27. Salem KA, Kosanovic M, Qureshi A, Ljubisavljevic M, Howarth FC. The direct effects of streptozotocin and alloxan on contractile function in rat heart. Pharmacol Res 59: 235-241, 2009.
28. Sauviat MP, Feuvray D. Electrophysiological analysis of the sensitivity to calcium in ventricular muscle from alloxan diabetic rats. Basic Res Cardiol 81: 489-496, 1986.
29. 2+ transporters by thyroid hormone. Mol Cell Biochem 129: 145-159, 1993.
30. Turner CW, Shenfield GM. The effect of thyroid dysfunction on the chronotropic response to noradrenaline. Eur J Pharmacol 68: 295-303, 1980.
31. Vadlamudi RV, Mcneill JH. Effect of experimental diabetes on isolated rat heart responsiveness to isoproterenol. Can J Physiol Pharmacol 62: 124-131, 1984.
32. Veglio M, Bruno G, Borra M, Macchia G, Bargero G, D'errico N, Pagano Gf, Cavallo-Perin P. Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J Intern Med 251: 317-324, 2002.
33. Veglio M, Chinaglia A, Cavallo PP. The clinical utility of QT interval assessment in diabetes. Diabetes Nutr Metab 13: 356-365, 2000.
34. Veglio M, Chinaglia A, Cavallo-Perin P. QT interval, cardiovascular risk factors and risk of death in diabetes. J Endocrinol Invest 27: 175-181, 2004.
35. Wexler BC, Lutmer RF. Adrenal glandular lipids and circulating corticosterone in severely diabetic rats. Br J Exp Pathol 56: 299-306, 1975.
36. Wheatley AM, Butkow N, Grote J, Musiker J, Rosendorff C. The effect of propranolol, verapamil and dantrolene treatment on cardiac hypertrophy, enhanced myocardial contractility and tachycardia in the hyperthyroid rat. Pharmacol Res 22: 307-318, 1990.
37. Yin YL, Perret GY, Nicolas P, Vassy R, Uzzan B, Tod M. In vivo effects of amiodarone on cardiac betaadrenoceptor density and heart rate require thyroid hormones. J Cardiovasc Pharmacol 19: 541-545, 1992.
38. + current. Cell Physiol Biochem 19: 225-238, 2007.
39. Zierhut W, Zimmer HG. Differential effects of triiodothyronine on rat left and right ventricular function and the influence of metoprolol. J Mol Cell Cardiol 21: 617-624, 1989.
40. Zola BE, Miller B, Stiles Gl, Rao PS, Sonnenblick EH, Fein FS. Heart rate control in diabetic rabbits: blunted response to isoproterenol. Am J Physiol 255: E636-E641, 1988.